GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
10
Funding Rounds
$232.3m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Be***** Gi*** |
|
- | |
| Jo** al*** sa*** | - | - | - |
| Lu* Va********** | - | - | |
| Se*** Pi**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Be***** Gi*** |
|
- | |
| Jo** al*** sa*** | - | - | - |
| Pe*** Go******** | - | - | |
| C�***** Mo**** | - | - |
The company GenSight Biologics has raised a total of $42.25m in funding over 10 rounds.